IMI (LON:IMI) “Underperform” Rating Reconfirmed Today By RBC Capital Markets; The PT Given is GBX 700


IMI (LON:IMI) Rating Reaffirmed

The brokerage has just set a target price of GBX 700 on IMI (LON:IMI) shares. This is -20.45% from the price per share. In a very recent research note announced on 15 December, RBC Capital Markets has decided to reaffirm their “Underperform” rating on shares of IMI.

From a total of 20 analysts covering IMI PLC (LON:IMI) stock, 4 rate it a ”Buy”, 4 a “Sell”, and 13 a ”Hold”. This means that 19% of the ratings are positive. The highest target price is GBX 1400 while the lowest target price is GBX 700. The mean of all analyst targets is GBX 996 with a 18.81% above today’s (GBX 880.5) stock price. IMI PLC was the topic of 66 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. Nomura maintained shares on December 15 with “Buy” rating. Peel Hunt maintained shares with “Hold” rating and GBX 900 target share price in a report from a November 27. Societe Generale maintained IMI stock in a recent report from December 4 with “Hold” rating. BNP Paribas maintained the rating on November 16. BNP Paribas has a “Underperform” rating and a GBX 775 price target on shares. Finally, Citigroup maintained the stock with “Neutral” rating in a report issued on a December 1.

Approximately 248,099 shares of stock traded hands. IMI plc (LON:IMI) has declined 26.59% since May 18, 2015 and is downtrending. It has underperformed by 22.91% the S&P500.


The overall sentiment of institutions has increased to 3 in Q2 2015. Its up 1.29, from 1.71 in 2015Q2. The ratio improved, as 1 institutions have sold all the shares of IMI plc that they owned while 4 funds have taken shares off the table. 4 funds have purchased shares for the first time while 11 added to their positions. These institutions now hold 17.46 million shares or 2.89% more than the 16.97 million shares they owned in 2015Q2.

The Fund Raging Capital Management Llc currently is holding shares equating to 2.82% of its total portfolio in IMI plc representing a total of 11.35 million shares. Another fund,Symmetry Peak Management Llc, is holding a total of 881,207 shares equating to 0.28% of their holdings. Additionally, 683 Capital Management Llc has a 112,129 share stake in IMI plc which represents 0.03% of their total portfolio. The Fund, Bridgeway Capital Management Inc, based out of Texas, has also built up a stake in the stock, which represents a total of 0.01% of their total portfolio. Finally Employees Retirement System Of Texas, a fund which is based in the state of Texas reported a total holdings of 470,000 shares.

Insider activity is a very important aspect to track on any stock. Going back to June 29, 2015, shareholders of IMI plc have witnessed 1 insider buy, and a total of 2 sales equating to a net activity of approximately $488,748 . Neely Rick sold 3,807 shares worth approximately $7,085. Martin William C bought 283,913 shares worth approximately $497,785.

IMI plc is a specialist engineering firm engaged in designing, manufacturing and servicing engineered products that control the precise movement of fluids. The company has a market cap of 2.40 billion GBP. The Company’s technologies, built around valves and actuators, enable processes to operate well. It has 13.6 P/E ratio. The Firm operates though the following divisions: IMI critical engineering, which provides flow control solutions; IMI precision engineering, which specializes in the design and manufacture of motion and fluid control technologies, and IMI hydronic engineering, which provides technologies that deliver water heating and cooling systems.

According to Zacks Investment Research, “Intermolecular, Inc. provides high productivity combinatorial technology products and services in order to accelerate research and development, innovation and time-to-market for the semiconductor and clean-energy industries. It also develops technology and intellectual property for its customers. The Company’s customers include semiconductor device, semiconductor materials and equipment, and clean-energy companies. Intermolecular, Inc. is headquartered in San Jose, California.”